The Missed Vital Sign — Execution
Funds United Kingdom women-centered health projects improving vital-sign linked maternal and child outcomes.
The Missed Vital Sign is a $50 million Wellcome Leap program targeting heavy menstrual bleeding (HMB), a condition that affects roughly one in four women yet takes an average of five years to receive a diagnosis or effective treatment. The program is structured as a time-bound, outcomes-focused initiative in which Wellcome Leap acts as a program director rather than a passive grant-maker, setting …
Heavy menstrual bleeding identification, diagnostics, and non-hormonal treatment research aimed at reducing the average duration women experience HMB from five years to five months.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility